Meropenem Kabi

Meropenem, the active ingredient in Meropenem Kabi, is a carbapenem antibiotic presented as an injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, and septicemia in hospitalized patients.

GNH USA supplies Meropenem Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a carbapenem antibiotic used to treat serious infections caused by susceptible bacteria.

- Complicated intra‑abdominal infections: effective against mixed aerobic and anaerobic pathogens, helping resolve infection. - Complicated urinary tract infections: eradicates Gram‑negative and some Gram‑positive organisms, facilitating clinical cure. - Nosocomial pneumonia: provides broad‑spectrum coverage for hospital‑acquired lung infections, improving patient outcomes. - Septicemia: rapidly reduces bloodstream bacterial load, supporting recovery in systemic infection.

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects: - Diarrhea: mild to moderate watery stools. - Nausea: feeling of sickness. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Severe allergic reactions: anaphylaxis or angioedema. - Clostridioides difficile colitis: severe diarrhea due to bacterial overgrowth.

When using Meropenem, consider the following precautions.

- Renal function: adjust dose in patients with impaired kidney function. - CNS disorders: monitor for seizures, especially in patients with a history of epilepsy. - Hypersensitivity: avoid use in patients with known allergy to carbapenems or β‑lactams. - Pregnancy and lactation: use only if benefit outweighs potential risk, as safety data are limited. - Concomitant valproic acid: may reduce serum levels, monitor seizure control. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Valproic acid: reduces valproate concentrations, may precipitate seizures. - Probenecid: may increase meropenem levels, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity, monitor renal function. - Loop diuretics: potential for increased ototoxicity when combined with aminoglycosides. - Anticoagulants (warfarin): may enhance anticoagulant effect, monitor INR.